CardieX Limited

Last Updated:
3:40 pm
Friday, June 27, 2025
CardieX Ltd. engages in the provision of designing, manufacturing, and marketing medical devices used in cardiovascular health management. It operates through the following geographical segments: Americas, Europe, and Asia Pacific. The Americas segment includes pharmaceutical trials business. The Europe segment focuses on the Middle East and Africa. The Asia Pacific segment is involved in the operations of Asia, Australia, and New Zealand. The company was founded by Ross Harricks, Niall Charles Edgar Cairns, Craig R. Cooper, and Michael Francis O'Rourke in 1994 and is headquartered in Sydney, Australia.
Market Cap
AU$21.45M
Volume
521681
Open
0.04
AU$
High
0.04
AU$
Low
0.04
AU$
Shares On Issue
303M
52 Week Low
0.038
AU$
52 Week High
0.171
AU$
Website
Sector
Healthcare
Medical Specialties
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report

Related

Our friendly team is here to help.

If you have any questions or feedback about our service, please feel free to contact us.